Publication | Open Access
Search of ligands suitable for 212Pb/212Bi in vivo generators
35
Citations
12
References
2012
Year
The short half-life of <sup>212</sup>Bi and <sup>213</sup>Bi limits the application of these radionuclides in α radionuclide therapy. The labeling of biomolecules with <sup>212</sup>Pb (mother nuclide of <sup>212</sup>Bi) instead of <sup>212</sup>Bi or <sup>213</sup>Bi has the advantage of obtaining a conjugate with a half-life of 10.6 h, compared with of 60 min for <sup>212</sup>Bi or 46 min for <sup>213</sup>Bi. Previous attempts to prepare a potential in vivo generator with <sup>212</sup>Pb complexed by the DOTA chelator failed, because about 36 % of Bi was reported to escape as a result of the radioactive decay [Formula: see text]. Herein, we report studies on the stability of the <sup>212</sup>Pb complexes with eight selected polydentate ligands, which demonstrate high affinity for 3+ metal cations. From the ligand studied DOTP and BAPTA show a sufficient <sup>212</sup>Pb labeling yields but only <sup>212</sup>Pb-DOTP complex is stable in isotonic solution of sodium chloride making this way radioactivity level of released <sup>212</sup>Bi is below the limit of detection. It should be emphasized that the DOTP complex is stable only in the case when the concentration of free DOTP exceeds 10<sup>-4</sup> M.
| Year | Citations | |
|---|---|---|
Page 1
Page 1